Press Room

 

Rebate Rule Raises Seniors’ Medicare Premiums to Pay for Pharmaceutical Industry Windfall

Washington, D.C., November 20, 2020 – Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the Trump…

Stakeholders Agree: Finalizing Trump Administration Rebate Rule Will Lead to Premium Increases for Seniors

Today, the Coalition for Affordable Prescription Drugs released the following statement regarding news that the Trump Administration is expected to finalize the…

CAPD Statement on Drug Companies’ Proposal to the White House

Today, the Coalition for Affordable Prescription Drugs released the following statement: “The ‘deal’ drug companies sent to the Administration…

CAPD Statement on the Administration’s Executive Order on Rebates

Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the Administration’s new Executive Order on…

CAPD Comment Letter on CMS Rule on Drug Utilization Review and Value-Based Purchasing (2482-P)

Monday, July 20, 2020 Seema Verma, AdministratorCenters for Medicare and Medicaid ServicesDepartment of Health and Human ServicesAttention: CMS-2482-PP.O….

CAPD Comment Letter on CMS-4190-P

Seema Verma, Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-4190-P P.O….

CAPD Comment Letter on HHS’ Notice of Benefit and Payment Parameters (NBPP)

Seema Verma, Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-9916-P P.O….

CAPD Statement on House Passage of H.R. 3

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement on the passage…